Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

JNJBMY

Johnson & Johnson

JNJ · $263.81

62Good

Bristol-Myers Squibb Company

BMY · $61.52

60Good

Area by area

Overall Quant Score

How does it look overall? (out of 100)

JNJ

62/100

BMY

60/100

Quality

Is it a profitable, well-run business?

JNJ

6.5/10

BMY

8.1/10

Growth

Is the company growing?

JNJ

5.3/10

BMY

4.5/10

Valuation

Is the price reasonable? (higher = cheaper)

JNJ

5.7/10

BMY

9.8/10

Risk

How risky are the shares? (higher = lower risk)

JNJ

9.1/10

BMY

7.6/10

Momentum

Is the share price trending up?

JNJ

8.4/10

BMY

8.0/10

Financial strength

Is the balance sheet healthy?

JNJ

7.2/10

BMY

3.7/10

The balanced view

Model-generated

Johnson & Johnson

This company scores above average, with a relatively low-risk profile and a positive price trend, although analysts are cautious.

Leads on: growth, risk, momentum, financial strength

Best feature: relatively low risk (Beta (vs. market): 0.23)

Watch out: analysts are cautious (Target upside: 8.1%)

Bristol-Myers Squibb Company

This company scores above average, with a reasonable valuation and strong profitability, although analysts are cautious.

Leads on: quality, valuation

Best feature: reasonable valuation (PEG: 0.16)

Watch out: analysts are cautious (Analyst buy share: 45%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.